Why the Up-C Structure Is a Good Alternative Route to an IPO

The umbrella partnership C corporation (Up-C) structure has been a popular option for pass-through entities looking to gain access to the capital markets.

More

Navigating SEC Comment Letters: Non-GAAP Disclosures and Metrics

Inevitably, companies looking to go public will face the prospect of comment letters from the Securities and Exchange Commission (SEC).

More

The Ultimate Guide to a Life Sciences IPO

The life sciences industry is in the middle of an IPO boom, with the 10 highest-valued biotech IPOs raising $3.

More

Meet Kelly Provost: A Leader in CFGI’s Life Sciences Capital Markets

Kelly Provost is a leader in CFGI’s Life Sciences Capital Markets practice and has dedicated her career to supporting companies that are trying to cure diseases and save lives, making a difference in the lives of people across the world.

More

The Future Is Already Here, and CFOs Need to Transform Finance to Survive

Download the Whitepaper

April Coleman: Former SEC Reviewer Spearheading CFGI’s Dedicated IPO Team

Experience is as good as gold in the accounting advisory world, and arguably no one at CFGI has spent as much time working both sides of the advisory/client aisle than Partner April Coleman.

More

Capital Markets Advisory: 2020 Year in Review

Despite the impact of the pandemic, 2020 was a record year for the U.

More

SPAC Mergers Are a Popular (and Accelerated)
Way to Go Public

In the first two quarters of 2020, special purpose acquisition companies (SPACs) raised more than $30 billion, according to SPAC Research, a major increase versus the $13 billion raised in the entirety of 2019.

More

How to Mitigate the Cheap Stock Issue When Preparing for an IPO

When a company embarks on an initial public offering (IPO), one of the most significant challenges in the registration process with the U.

More